Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Sweating, Too Much and Too Little
Description
The presentation discusses the physiology and clinical implications of sweating disorders, specifically hyperhidrosis (excessive sweating) and hypohidrosis (insufficient sweating). The speaker, Smile, emphasizes the critical roles of sweat glands, which not only help regulate body temperature through sweat evaporation but also contain antimicrobial peptides and skin stem cells that aid in wound healing. Various aspects of sweat physiology, including the types of cells in sweat glands, their innervation, and differences in sweat composition based on sex, are described. The distinction between hyperhidrosis and hypohidrosis symptoms is noted, highlighting that patients often seek help for excessive sweating while insufficient sweating may go unnoticed. Innovative diagnostic tools such as sweat testing, typically used for cystic fibrosis, are proposed as useful for dermatological assessments. The talk further delves into ectodermal dysplasias, expanding on recent shifts in classification that emphasize congenital aspects of the condition. Treatment advances, including gene modification and protein therapies administered during pregnancy, show promise for improving outcomes in affected children. The presentation concludes by asserting that while sweating plays a vital role in skin homeostasis and should be monitored closely, further updates in the classification of ectodermal dysplasias are anticipated every five years to enhance understanding and treatment options.
View moreConclusions
- Sweating is essential for regulating body temperature and promoting skin homeostasis.
- Hyperhidrosis is a common consultation complaint, while hypohidrosis often goes unreported.
- Ectodermal dysplasias are genetic conditions affecting multiple ectodermal derivatives.
- New treatment approaches, including prenatal therapy, have shown promise for conditions like X-linked hypohidrotic ectodermal dysplasia (XLHED).
- Amniotic infusion of EDA can restore sweat production to normal levels in affected individuals.
- There is a need for greater awareness and testing for anhidrosis in clinical settings.
- The definition and classification of ectodermal dysplasias have been updated to include more variants and clarify their genetic underpinnings.
- Innovative therapies are being developed to address the challenges presented by rare skin diseases.
- Bovell D J Local & Global Health Science 2015: 5
- Schneider H et al. Int. J. Mol. Sci. 2023, 24, 7155
- Burian M et al, J Invest Dermatol 2015; 135:759-67
- Na CH et al. Mol Cell Proteomics. 2019;18 :1382-1395
- Elpa DP et al. Trends in Endocrinology and Metabolism, 2021. 32: 66-75.
- Wright T et al ., Am J Med Genet, 2019; 179: 442-7
- Peschel N et al ., Genes, 2022; 13: 2327
- Schneider H et al. Int. J. Mol. Sci. 2023, 24, 7155
- Cai Z et al. Front. Physiol. 12:788411
- Yang, R. et al Int. J. Mol. Sci. 2022, 23, 8911
- Schneider et al, N Engl J Med. 2018, 26 ; 378 : 1604-10